Wu S - Search Results

1

Focus on the Crosstalk between COVID-19 and Urogenital Systems.

Wu ZS, Zhang ZQ, Wu S. Wu ZS, et al. Among authors: wu s. J Urol. 2020 Jul;204(1):7-8. doi: 10.1097/JU.0000000000001068. Epub 2020 Apr 3. J Urol. 2020. PMID: 32249664 Free PMC article. No abstract available.

2

Extracellular vesicles in urologic malignancies-Implementations for future cancer care.

Wu Z, Zhang Z, Xia W, Cai J, Li Y, Wu S. Wu Z, et al. Among authors: wu s. Cell Prolif. 2019 Nov;52(6):e12659. doi: 10.1111/cpr.12659. Epub 2019 Aug 30. Cell Prolif. 2019. PMID: 31469460 Free PMC article. Review.

3

Communication Of Cancer Cells And Lymphatic Vessels In Cancer: Focus On Bladder Cancer.

Wu ZS, Ding W, Cai J, Bashir G, Li YQ, Wu S. Wu ZS, et al. Among authors: wu s. Onco Targets Ther. 2019 Oct 3;12:8161-8177. doi: 10.2147/OTT.S219111. eCollection 2019. Onco Targets Ther. 2019. PMID: 31632067 Free PMC article.

4

Current status and future perspectives of immunotherapy in bladder cancer treatment.

Wu Z, Liu J, Dai R, Wu S. Wu Z, et al. Among authors: wu s. Sci China Life Sci. 2021 Apr;64(4):512-533. doi: 10.1007/s11427-020-1768-y. Epub 2020 Aug 26. Sci China Life Sci. 2021. PMID: 32926318 Review.

5

Transcription factor YY1 mediates epithelial-mesenchymal transition through the TGFβ signaling pathway in bladder cancer.

Xia W, Li Y, Wu Z, Wang Y, Xing N, Yang W, Wu S. Xia W, et al. Among authors: wu s, wu z. Med Oncol. 2020 Sep 24;37(10):93. doi: 10.1007/s12032-020-01414-5. Med Oncol. 2020. PMID: 32970204

6

Magnetic-Powered Janus Cell Robots Loaded with Oncolytic Adenovirus for Active and Targeted Virotherapy of Bladder Cancer.

Cong Z, Tang S, Xie L, Yang M, Li Y, Lu D, Li J, Yang Q, Chen Q, Zhang Z, Zhang X, Wu S. Cong Z, et al. Among authors: wu s. Adv Mater. 2022 Jul;34(26):e2201042. doi: 10.1002/adma.202201042. Epub 2022 May 27. Adv Mater. 2022. PMID: 35452560

7

The era of personalized treatments: Updates on immunotherapy within urothelial of bladder cancer.

Wu ZS, Wu S. Wu ZS, et al. Among authors: wu s. Curr Urol. 2022 Sep;16(3):117-120. doi: 10.1097/CU9.0000000000000133. Epub 2022 Aug 27. Curr Urol. 2022. PMID: 36204361 Free PMC article.

8

Somatic mutation of the androgen receptor gene is not associated with transitional cell carcinoma: a "negative" study by whole-exome sequencing analysis.

Wu S, Lv Z, Zhu J, Dong P, Zhou F, Li X, Cai Z. Wu S, et al. Eur Urol. 2013 Dec;64(6):1018-9. doi: 10.1016/j.eururo.2013.07.040. Epub 2013 Aug 7. Eur Urol. 2013. PMID: 23954086 No abstract available.

9

Telomerase reverse transcriptase gene promoter mutations help discern the origin of urogenital tumors: a genomic and molecular study.

Wu S, Huang P, Li C, Huang Y, Li X, Wang Y, Chen C, Lv Z, Tang A, Sun X, Lu J, Li W, Zhou J, Gui Y, Zhou F, Wang D, Cai Z. Wu S, et al. Eur Urol. 2014 Feb;65(2):274-7. doi: 10.1016/j.eururo.2013.10.038. Epub 2013 Nov 5. Eur Urol. 2014. PMID: 24215939

10

Abdominal Aortic Dissection in a Patient With Autosomal Dominant Polycystic Kidney Disease After Starting Peritoneal Dialysis.

He Y, Wang Q, Zhang M, Wang B, Xiong Z, Luo Q, Wu S. He Y, et al. Among authors: wu s. Urol Case Rep. 2014 May 17;2(4):123-5. doi: 10.1016/j.eucr.2014.04.004. eCollection 2014 Jul. Urol Case Rep. 2014. PMID: 26839787 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

40,438 results

Search Page

Filters